Summary
Directs the U.S. to create a plan with other countries and groups for making and selling products that fight pandemics and drug-resistant germs.
What problem does this solve?
Infectious diseases and drug-resistant germs from other countries are a big threat to America's safety, health, and economy. This bill requires the U.S. to create a global plan with other nations to develop medical products to stop these threats before they reach the U.S.
Who does this affect?
- U.S. Department of State
- U.S. Department of Health and Human Services
- Medical and pharmaceutical companies
What does this bill do?
Reference
Text:
Section:
Sec. 4(a)(1)
Header:
International strategy for development of qualified pandemic or epidemic products
Creates a global pandemic strategy
Requires the Secretary of State to create a formal plan for the U.S. to work with other countries and groups to develop and sell products that fight pandemics and epidemics.
Focuses on drug-resistant germs
Specifies that the strategy must address antimicrobial resistant pathogens, also known as 'super bugs,' that have pandemic potential or are considered priority threats.
Promotes fair international contributions
Ensures the plan encourages partner countries and organizations to contribute fairly based on their budgets and technical skills, rather than the U.S. funding everything.
Strengthens health systems in other countries
Supports efforts to improve the ability of partner countries to prevent, find, and stop infectious disease threats on their own.
Involves private companies
Considers using contracts with U.S. companies, creating public-private partnerships, and making it easier for new products to get approved and paid for.
What is the real world impact?
•
Protects the U.S. from foreign health threats
Aims to stop infectious disease outbreaks in other countries before they can spread and become a direct threat to the health, economy, and military readiness of the United States.
•
Strengthens U.S. leadership in global health
Positions the United States at the center of international efforts to fight pandemics, leveraging its technology and companies to lead the global response and shape international health priorities.
When does this start?
Requires a global strategy to be created and submitted to Congress within 18 months of the bill becoming law.
Deadline for global strategy
The Secretary of State must formulate and submit the strategy to Congress no later than 18 months after the date the Act is passed.